Study says 80% of pharma pros report batch-release delays
In short
A study says 80% of surveyed pharma manufacturing workers reported delays in releasing batches. The report blamed open investigations, paperwork and supervision limits.
This matters because delays can slow factory output and hurt India’s drug-making plans. The source does not say which companies were affected or how big the survey was.
What the reporting says
A Vector Consulting Group study found that 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays because of open investigations, according to a publisher-supplied summary. The report also cited incident backlogs, documentation requirements and supervisory constraints as factors affecting factory productivity. The source does not name the survey size, affected companies, or when the study was conducted.
Why it matters
A Vector Consulting Group study says 80% of surveyed pharmaceutical manufacturing professionals reported batch-release delays tied to open investigations, according to the publisher-supplied summary. The findings point to incident backlogs, documentation demands and supervisory constraints as productivity issues for drug factories. The reporting does not identify the surveyed firms, sample size or specific facilities, so the scale of the problem across India’s pharma sector remains unclear.